The National Center on Addiction and Substance Abuse at Columbia University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, The National Center on Addiction and Substance Abuse at Columbia University sits in the top decile of US sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count).

10 total trials 2 currently recruiting 8 completed early-phase tilt top decile by trial count

The National Center on Addiction and Substance Abuse at Columbia University: 10 sponsored US clinical trials, 2 recruiting.

The National Center on Addiction and Substance Abuse at Columbia University sponsors 10 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 8 completed. 0 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Substance Use, with 2 trials.

Top-decile sponsor footprint

The National Center on Addiction and Substance Abuse at Columbia University ranks in the top decile of sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

10 total, page 1 of 1

RECRUITING NA

Family Support Protocol for Adolescent Internalizing Disorders

NCT06413979
RECRUITING NA

Primary Connections for Youth and Families

NCT05964010
COMPLETED NA

BabySTEPs: Supportive Texts to Empower Parents

NCT04719390
COMPLETED NA

Home Visitation Enhancing Linkages Project

NCT03750487
COMPLETED NA

Measurement Training and Feedback System: Family Therapy and CBT

NCT03722654
COMPLETED NA

Measurement Training and Feedback System: Family-Based Services

NCT03342872
COMPLETED NA

Integrated Treatment for Adolescents With ADHD

NCT02420990
COMPLETED Phase 1

Medication Integration in Treatment of Comorbid Adolescent Substance Users/Attention Deficit Hyperactivity Disorder

NCT01369459
COMPLETED Phase 1

Family-Based Protocol for Medication Integration in Treatment of Comorbid ASU/ADHD in Routine Care

NCT01539941
COMPLETED

Learning Effective Approaches to Prevention

NCT00985595

Phase Distribution

PhaseTrial count
Phase 1 2

Therapeutic Areas

Substance Use 2
Internalizing Disorders 1
Attention Deficit Disorder 1
Attention Deficit Hyperactivity Disorder 1
Adolescent Behavior 1
Substance Use Disorders 1

What is open in the The National Center on Addiction and Substance Abuse at Columbia University pipeline

2 recruiting of 10 indexed (20% open); 8 completed (80%).

Phase mix: 0 late (III/IV) vs 2 early (I/II) (early-phase heavy).

Top condition: Substance Use (2 trials), 5 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

The National Center on Addiction and Substance Abuse at Columbia University: open-pipeline peers nationwide

Peers matched on 10 registered trials and 20% open enrollment, not the therapeutic-area sidebar.

The National Center on Addiction and Substance Abuse at Columbia University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 4681012 0%10%20%30%40% Total trials Recruiting share The National Center on Addiction and Substance Abuse at Columbia UniversityAdamas PharmaceuticalsAdverum BiotechnologiesAevi Genomic Medicine, LLC, a Cerecor companyAgouron PharmaceuticalsAcera SurgicalAlign TechnologyAltruBioAlvernia University
The National Center on Addiction and Substance Abuse at Columbia University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

The National Center on Addiction and Substance Abuse at Columbia University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 10 trials (± recruiting share)

Sponsors near 20% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this The National Center on Addiction and Substance Abuse at Columbia University page

10 registered trials is a research-attention snapshot, not an endorsement of The National Center on Addiction and Substance Abuse at Columbia University or any single study.

  • 2 of The National Center on Addiction and Substance Abuse at Columbia University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Substance Use is the condition The National Center on Addiction and Substance Abuse at Columbia University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Substance Use trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

The National Center on Addiction and Substance Abuse at Columbia University pipeline card: 10 registered trials from official public datasets.Report a data error.